1785079703417

Transcript: Former FDA commissioner Dr. Scott Gottlieb on “Face the Nation with Margaret Brennan,” July 26, 2026

The following is the transcript of an interview with U.S. Ambassador to the United Nations Mike Waltz that aired on “Face the Nation with Margaret Brennan” on July 26, 2026. MARGARET BRENNAN: We turn now to former FDA Commissioner Dr. Scott Gottlieb. He sits on the boards of Pfizer and UnitedHealth. Dr. Gottlieb, it’s good…

Read More
restrictedimagesub

Full transcript of “Face the Nation with Margaret Brennan,” July 26, 2026

On this “Face the Nation with Margaret Brennan” broadcast, moderated by Margaret Brennan:  Republican Sen. John Kennedy of Louisiana Independent Sen. Bernie Sanders of Vermont U.S. Ambassador to the United Nations Mike Waltz Former FDA Commissioner Dr. Scott Gottlieb A look at new CBS News polling with Anthony Salvanto, CBS News’ executive director of elections and surveys Click here to browse full transcripts from…

Read More
gettyimages 2285892126

Cyclospora outbreak dubbed “lettuce-gate” as concerns over parasitic illness spread across U.S.

As the cyclospora outbreak linked to iceberg lettuce spread to nine states, Americans have dubbed the health concern “lettuce-gate” on social media, and they aren’t convinced the situation is under control. Days after Health Secretary Robert F. Kennedy Jr. tried to calm growing concerns about the parasitic illness, saying that the source of the outbreak has been…

Read More
gettyimages 2287065447

Trump says U.S. will investigate EU trade practices, claiming unfair fines against tech companies

Washington — President Trump said Friday that his administration is launching an investigation into the European Union’s trade practices over billions of dollars in fines imposed on the United States’ biggest tech companies. In a post on Truth Social, Mr. Trump said the investigation under Section 301 of the Trade Act is beginning “immediately” and…

Read More
1784874895 gettyimages 2200929852

FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies

A Food and Drug Administration advisory panel voted to broaden access to at least one peptide during a two-day meeting discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes during a surge of interest in the unapproved therapies. Peptides are short strings of amino acids, the building blocks of proteins, linked by…

Read More